Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection.
Walgenbach
K J
KJ
Department of Surgery, University of Bonn, Germany.
Llull
R
R
Murase
N
N
Starzl
T E
TE
Hirner
A
A
D000818:Animals; D002908:Chronic Disease; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology; D006614:Hindlimb / Q000637:transplantation*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017403:In Situ Hybridization; D018482:Muscle, Skeletal / Q000276:immunology / Q000637:transplantation; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D012867:Skin / Q000276:immunology; D016038:Skin Transplantation / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta / Q000096:biosynthesis*; D014184:Transplantation, Homologous / Q000276:immunology; D014185:Transplantation, Isogeneic / Q000276:immunology
D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D016559:Tacrolimus